Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical International Technology (MIT) is a specialized medical device company focused on the development, manufacturing, and commercialization of needle-free jet injection systems for both human and animal health. The company's core technology, the Med-Jet and Agro-Jet product lines, utilizes low-pressure jet injection to deliver vaccines and medications without the use of traditional needles, significantly reducing the risk of cross-contamination and needle-stick injuries. MIT's systems are designed for a wide range of applications, including mass vaccinations, insulin delivery, and local anesthesia, and have received regulatory clearances in multiple international markets, including the US and China. By providing a safer and more efficient alternative to conventional syringes, the company aims to improve patient compliance and global healthcare sanitation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Technology.